CT预测膀胱癌治疗反应的诊断准确性:有无计算机决策支持系统的比较
回顾性收集123例157个肌层浸润性膀胱癌病灶的新辅助化疗前后CT,评估基于CT的计算机决策支持系统(CDSS-T)能否提高完全缓解识别。CDSS-T单独AUC 0.80,医生不用CDSS-T为0.74,使用后为0.77,医生性能提升有统计学意义(P < .05)。
要点
- CDSS-T辅助可使医生判断病理T0的AUC从0.74升至0.77(P < .05)。
- CDSS-T单独判断病理T0的AUC为0.80,高于医生不用或使用CDSS-T。
- 多读者多病例ROC分析显示CDSS-T可改善完全缓解识别。
核心结论
- CDSS-T可提高医生识别肌层浸润性膀胱癌对新辅助化疗完全缓解的性能。
研究设计与样本
- 回顾性研究,纳入123例受试者共157个肌层浸润性膀胱癌病灶,收集化疗前后CT;CDSS-T结合深度学习卷积神经网络与影像组学特征,采用留一病例交叉验证;5名腹部放射科主治医师、4名放射科住院医师、2名肿瘤科主治医师和1名泌尿外科主治医师在自研图形界面上先独立评估,再参考CDSS-T似然评分修正;采用多读者多病例ROC方法分析。
诊断标准与关键数值
- 评估对象为病理T0疾病(完全缓解);CDSS-T单独AUC 0.80,医生不用CDSS-T AUC 0.74,医生使用CDSS-T AUC 0.77,医生性能提升P < .05。
临床应用与阅片要点
- 医生可先独立阅片评估肌层浸润性膀胱癌新辅助化疗后病理T0可能性,再参考CDSS-T似然评分修正判断;原文显示该流程可提高识别完全缓解的AUC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate whether a computed tomography (CT)-based computerized decision-support system for muscle-invasive bladder cancer treatment response assessment (CDSS-T) can improve identification of patients who have responded completely to neoadjuvant chemotherapy.
MATERIALS AND METHODS: Following Institutional Review Board approval, pre-chemotherapy and post-chemotherapy CT scans of 123 subjects with 157 muscle-invasive bladder cancer foci were collected retrospectively. CT data were analyzed with a CDSS-T that uses a combination of deep-learning convolutional neural network and radiomic features to distinguish muscle-invasive bladder cancers that have fully responded to neoadjuvant treatment from those that have not. Leave-one-case-out cross-validation was used to minimize overfitting. Five attending abdominal radiologists, four diagnostic radiology residents, two attending oncologists, and one attending urologist estimated the likelihood of pathologic T0 disease (complete response) by viewing paired pre/post-treatment CT scans placed side-by-side on an internally-developed graphical user interface. The observers provided an estimate without use of CDSS-T and then were permitted to revise their estimate after a CDSS-T-derived likelihood score was displayed. Observer estimates were analyzed with multi-reader, multi-case receiver operating characteristic methodology. The area under the curve (AUC) and the statistical significance of the difference were estimated.
RESULTS: The mean AUCs for assessment of pathologic T0 disease were 0.80 for CDSS-T alone, 0.74 for physicians not using CDSS-T, and 0.77 for physicians using CDSS-T. The increase in the physicians' performance was statistically significant (P < .05).
CONCLUSION: CDSS-T improves physician performance for identifying complete response of muscle-invasive bladder cancer to neoadjuvant chemotherapy.
引用
- Cha KH, Hadjiiski LM, Cohan RH, et al. Diagnostic Accuracy of CT for Prediction of Bladder Cancer Treatment Response with and without Computerized Decision Support. Acad Radiol. 2018. PMID: 30424999. doi:10.1016/j.acra.2018.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。